Jacob Gunterberg - Profile and Investment Details

Investor Profile

Jacob Gunterberg is a Venture Capital based in Stockholm, Stockholm County, Sweden with a diverse investment portfolio that includes companies such as Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG, Renovis, Aprea, Immune Targeting SystemsGlionova, LTB4 Sweden, MIPS AB, ChemoCentryx, Oncos Therapeutics, Gyros, PTC Therapeutics, SynOx Therapeutics, Precirix, Renovo, Hybrigenics, GenSight Biologics, OraPharma Inc. (acquired by JNJ), Pulmonx, Cardoz, Biolipox, InCarda Therapeutics, Jerini, Orexo, Nexstim, Five Prime Therapeutics, BeneChill, Modus Therapeutics, Wilson Therapeutics, Algeta, BioStratum, Alba Therapeutics, Aro Biotherapeutics, Vicore Pharma AB, Carisma Therapeutics, Actelion Pharmaceuticals, Idea, Pharmion, Strongbridge Biopharma, CoreValve, Dynavax Technologies, SpineVision, Ultragenyx Pharmaceutical, FerroKin Biosciences, Resistentia Pharmaceuticals, Cytos, Doctrin, Rainier Therapeutics, Sopherion Therapeutics, Lumavita, Oncorena, Trimb Healthcare, Tisbury Pharmaceuticals, Nucleonics, Vivet Therapeutics, Altimmune, Fusion Pharmaceuticals, Aros Securities, Bionaut Pharmaceuticals, OxThera, Tengion, . Over time, Jacob Gunterberg has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jacob Gunterberg is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Software, Biotechnology, Clinical Trials, Health Diagnostics, Medical, Therapeutics, Pharmaceuticals, Service Industry may find it worthwhile to explore potential connections with Jacob Gunterberg, as their portfolio suggests a familiarity and interest in this area.

Understanding Jacob Gunterberg’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.